CCM
SWTX

CAAS Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

CAAS Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-112,643
Closed -$7.15M – 1159
2021
Q3 		$7.15M Buy
+112,643
New +$8.68M 0.54% 152
2021
Q2 		– Sell
-224,886
Closed -$16.5M – 1372
2021
Q1 		$16.5M Buy
224,886
+90,364
+67% +$7.08M 0.5% 132
2020
Q4 		$9.76M Buy
+134,522
New +$8.66M 0.31% 210

Other funds holding SWTX

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return